about
Transcriptional profiles of the response to ketoconazole and amphotericin B in Trichophyton rubrum.Mechanism of amphotericin B resistance in Leishmania donovani promastigotes.Amphotericin B inhibits the generation of the scrapie isoform of the prion protein in infected cultures.Production and characterization of stable amphotericin-resistant amastigotes and promastigotes of Leishmania mexicana.Nanodisks protect amphotericin B from ultraviolet light and oxidation-induced damage.Activity of a heat-induced reformulation of amphotericin B deoxycholate (fungizone) against Leishmania donovaniAmphotericin B colloidal dispersion.Recent progress in the study of the interactions of amphotericin B with cholesterol and ergosterol in lipid environments.The therapeutic potential of inhibitors of the trypanothione cycle.From nature to the laboratory and into the clinicThe amphotericin B lipid complex or Abelcet: its Belgian connection, its mode of action and specificity: a review.The transmissible spongiform encephalopathies: pathogenic mechanisms and strategies for therapeutic intervention.Self-assembled amphotericin B-loaded polyglutamic acid nanoparticles: preparation, characterization and in vitro potential against Candida albicans.Cytochrome P450 Enzyme Metabolites in Lead Discovery and Development.How can micelle systems be rebuilt by a heating process?Antifungal hydrogels.Osmotic Effects Induced by Pore-Forming Agent Nystatin: From Lipid Vesicles to the Cell.Amphotericin B induces interdigitation of apolipoprotein stabilized nanodisk bilayers.The effect of sterols on amphotericin B self-aggregation in a lipid bilayer as revealed by free energy simulations.Salvage treatment with amphotericin B in progressive human alveolar echinococcosis.Optimizing efficacy of amphotericin B through nanomodification.Optimizing efficacy of Amphotericin B through nanomodification.A unified approach to polyene macrolides: synthesis of candidin and nystatin polyols.Nanobiotechnology applications of reconstituted high density lipoprotein.Lipid-like properties and pharmacology of the anthelmintic macrocyclic lactones.Activation of stress signalling pathways enhances tolerance of fungi to chemical fungicides and antifungal proteins.Understanding Drug Release Data through Thermodynamic AnalysisPolyene macrolide biosynthesis in streptomycetes and related bacteria: recent advances from genome sequencing and experimental studies.pH regulation of amphotericin B channels activity in the bilayer lipid membrane.Clinical Response with intralesional Amphotericin B in the treatment of old world cutaneous leishmaniasis: a preliminary report.Biosynthesis and characterization of silver nanoparticles produced by Pleurotus ostreatus and their anticandidal and anticancer activities.Efficacy of an oral and tropically stable lipid-based formulation of Amphotericin B (iCo-010) in an experimental mouse model of systemic candidiasisThe customised electronic nebuliser: a new category of liquid aerosol drug delivery systems.A sensitive amphotericin B immunoassay for pharmacokinetic and distribution studies.Antimicrobials and in vitro systems: antibiotics and antimycotics alter the proteome of MCF-7 cells in culture.Novel oral amphotericin B formulation (iCo-010) remains highly effective against murine systemic candidiasis following exposure to tropical temperature.Effect of amphotericin B on larval growth of Echinococcus multilocularis.Cooperative partition model of nystatin interaction with phospholipid vesicles.Amphotericin B channels in the bacterial membrane: role of sterol and temperature.Reconstituted high density lipoprotein enriched with the polyene antibiotic amphotericin B.
P2860
Q33261315-3BCBA73B-FB20-4A27-BE9B-D3EB95AC4767Q33689898-0A9D237F-1807-4BD5-83B7-B563DFA4B2F6Q33801179-5DC83ED8-3357-4487-8BA4-3019AAE4C404Q33938137-55677BF0-A220-40BD-A9EA-CF02E72FC151Q33946948-DAC0222C-AC89-4A14-8473-C58717F49904Q33976111-4DBF80C8-F69A-4369-AB9C-AF5FAFF5CB89Q34182190-DEFC4C7F-DB47-4F59-BCB4-B6A4FC0011D2Q34417313-A16A839A-E92E-4FD3-A282-5EDA5466A52DQ34519134-728DB06B-D21C-431D-903D-723D55FF7F65Q34657694-924DFAE7-EA8A-4F83-A807-BC8B3A01DDE3Q34769519-E06D13ED-DB64-4994-9CDD-7E3D12E3D8D6Q35050425-540E387F-22A8-427B-A42A-394ED0142F50Q35168703-46ACF086-6758-4ABB-B176-A194F001BA36Q35194778-08E45AB9-4A1F-4F3B-B848-F865B779F373Q35686909-581E07BE-96B5-4EE8-8A21-CC2DE0847E45Q35928823-A2A0E5E6-00D1-4FF7-999D-EE26EF93FE6EQ36176134-C2D07AF7-FE72-4F72-A698-AFE0E27D2C08Q36477796-D2795180-47C3-4DC7-B44D-79F78942F0ADQ36742704-B7F6E452-C9ED-47F9-9578-FE6CAD146E6BQ36880781-254F0E5A-C38B-4BA5-A8F2-14EF261BB3BBQ36920328-AAD93F40-5AA4-434E-981C-219030A8732FQ37178176-54DC8687-B35C-4F9A-B5D4-AB850D053AAFQ37484218-6486387B-CE64-4FE6-BEAD-65AB98315392Q37814488-87DF4E4B-230D-45D7-80FC-C89316E58688Q38139573-52C6FC97-CA4C-4414-84CE-94BAA9929A98Q38187883-09B96234-FF78-41EF-8CB9-6CC0AFC1E965Q38643492-51862C07-EC12-48C7-96DA-B8E2CD586A90Q38792678-27399228-42D4-4CD8-9C8D-A15CFFFDA9D6Q38806796-B536E173-DE6D-407F-B7E5-F43DB90EF41FQ38914470-BB94E4C8-730B-491C-B748-EE21B4526AF8Q38972615-95943201-28B6-46F3-B0B7-BAA709197309Q39091841-B8385B8A-52B0-4E25-9468-29E3DDDA68C6Q39359025-2545CE99-80AF-4214-A7DD-E334AE42893CQ39473015-1D620208-94E5-4688-A24D-45173289FD65Q39561039-ACDFE575-8F3A-410C-97F2-A655E47EAE77Q39579669-4887095B-3D98-4E07-8A0E-15D3C5BB5552Q39740486-7E36C685-6C69-42AE-9720-4B4083934858Q40235657-D2D5AAEF-CE31-4979-A3F6-CB56A0642618Q40255952-DFD04C4D-C587-40EF-A0C3-2B3721FFCA0EQ40346394-90CDB2BD-3217-4755-9C03-2CE76587E61C
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Amphotericin B: new life for an old drug.
@en
type
label
Amphotericin B: new life for an old drug.
@en
prefLabel
Amphotericin B: new life for an old drug.
@en
P1476
Amphotericin B: new life for an old drug.
@en
P2093
P304
P356
10.1016/S0165-6147(96)01012-7
P577
1996-12-01T00:00:00Z